Cameron works closely with members of the local biotechnology community to manage their IP portfolios and develop their patent strategy. Clients range from large publicly listed biotechnology companies to smaller ‘start-up’ companies and university commercialisation bodies.
Cameron has completed a bachelor of Biotechnology (honours) and has a PhD in molecular biology. Cameron’s honours research project investigated neuronal changes that occur during chronic heart failure development and how these changes might be targeted to slow or arrest the progression of this disease.
During his honours year, Cameron also won the Nick McClure Prize in Enterprise Management, graduating top of his class in a course designed to develop the skills required for the commercialisation of technology via a ‘start-up’ biotechnology company.
Cameron’s PhD research focused on a class of small RNA molecules known as microRNA’s. His studies investigated the role of microRNA’s in an upper gastrointestinal disease sequence characterised by its systematic progression from gastroesophageal reflux disease (GORD) to Barrett’s oesophagus and oesophageal cancer. His research projects focused on investigating microRNA mediated mechanisms for cancer development, in addition to characterising microRNAs as useful diagnostic and prognostic biomarkers.
Cameron is a registered Australian Patent and Trade Marks Attorney.